Anzeige
Mehr »
Freitag, 31.10.2025 - Börsentäglich über 12.000 News
Attestation ist die Killer-App - Republic baut sie jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
31.10.25 | 13:39
143,80 Euro
+0,59 % +0,85
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
148,30150,2020:11
148,60149,9020:11

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.10.ICON PLC: EPS übertrifft Schätzungen um 0,01 $ - Umsatz besser als erwartet14
22.10.ICON plc: ICON Reports Third Quarter 2025 Results307Highlights Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net income for the quarter was $2.4 million or $0.03 per diluted share. ...
► Artikel lesen
22.10.ICON PLC - 6-K, Report of foreign issuer1
21.10.ClearBridge Select Strategy buys REGN, VRTX & VST; exits ICLR, PCTY & ADBE24
24.09.ICON plc Schedules Third Quarter 2025 Earnings Conference Call364ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday...
► Artikel lesen
ICON Aktie jetzt für 0€ handeln
04.09.ICON CEO Steve Cutler To Retire; Promotes COO Barry Balfe As New CEO8
04.09.ICON plc: ICON Announces CEO Transition326ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the...
► Artikel lesen
04.09.ICON PLC - 6-K, Report of foreign issuer6
02.09.ICON plc to Participate at Upcoming Investor Conferences322ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Barry Balfe, COO of ICON plc, will present at the Baird 2025...
► Artikel lesen
26.08.ICON PLC - 6-K, Report of foreign issuer1
13.08.ICON suspends COVID vaccine study after BARDA notice6
12.08.ICON PLC - 6-K, Report of foreign issuer1
30.07.Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-0017
29.07.Hoth Therapeutics, Inc.: Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe306The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/...
► Artikel lesen
24.07.ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery8
23.07.ICON Plc Q2 Profit Climbs10
23.07.ICON PLC - 6-K, Report of foreign issuer1
23.07.ICON plc: ICON Announces Results of Annual General Meeting307ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM)...
► Artikel lesen
23.07.ICON plc: ICON Reports Second Quarter 2025 Results484Highlights Gross business wins in the quarter of $2,966 million, representing an increase of 10.6% on quarter one 2025. Net business wins in the quarter of $2,057 million; a net book...
► Artikel lesen
16.07.ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report762ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1...
► Artikel lesen
Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1